The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 12, 2018

Filed:

Mar. 26, 2015
Applicant:

Surmodics, Inc., Eden Prairie, MN (US);

Inventors:

Joseph Schmidt McGonigle, Minneapolis, MN (US);

Aleksey V. Kurdyumov, Maplewood, MN (US);

Jeffrey J. Missling, Eden Prairie, MN (US);

Nathan A. Lockwood, Minneapolis, MN (US);

Kevin W. Burton, Hoover, AL (US);

Beth A. Petersen, Glencoe, MN (US);

Assignee:

Surmodics, Inc., Eden Prairie, MN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/00 (2006.01); A61K 9/70 (2006.01); A61K 31/573 (2006.01); A61K 9/00 (2006.01); A61K 47/34 (2017.01); A61L 29/06 (2006.01); A61L 29/14 (2006.01); A61L 29/16 (2006.01); A61L 31/04 (2006.01); A61F 2/07 (2013.01); A61F 2/82 (2013.01); A61L 31/10 (2006.01);
U.S. Cl.
CPC ...
A61K 9/7007 (2013.01); A61K 9/0024 (2013.01); A61K 31/573 (2013.01); A61K 47/34 (2013.01); A61L 29/06 (2013.01); A61L 29/14 (2013.01); A61L 29/16 (2013.01); A61F 2/07 (2013.01); A61F 2/82 (2013.01); A61L 31/04 (2013.01); A61L 31/10 (2013.01); A61L 2300/404 (2013.01); A61L 2300/406 (2013.01);
Abstract

A biocompatible polymeric controlled release matrix barrier structure for delivery of one or more bioactive agents from an implantable medical device is described. In an embodiment, a biocompatible polymeric controlled release matrix barrier structure is included. The biocompatible polymeric controlled release matrix can include a body structure formed of a compliant material comprising one or more compliant biocompatible polymers and one or more bioactive agents. The body structure can define a central aperture through which a subcutaneous element of an implantable medical device passes. Other embodiments are included herein.


Find Patent Forward Citations

Loading…